This webinar introduces the technology behind metabolic phenotyping using global Precision Metabolomics™. Dr. Kirk Pappan, Associate Director, Discovery and Translational Sciences at Metabolon, discusses recent examples of research in Type 2 diabetes, a common metabolic disease, which is being aided by metabolomics in discovery-focused and clinical settings.


Presented by
Kirk Pappan, Ph.D.
Kirk Pappan is an Associate Study Director at Metabolon.

Sign Up